欧洲50岁以上糖尿病患者季节性流感疫苗接种覆盖率及接种的社会决定因素:基于2019-2020和2021-2022流感季SHARE人群数据的分析
该横断面研究利用欧洲SHARE调查2019-2020和2021-2022流感季数据,纳入50岁以上糖尿病患者,计算加权流感疫苗接种率并分析社会决定因素。结果显示2021-2022季接种率54%显著高于2019-2020季的46%;两个流感季均与接种正相关的因素包括年龄≥65岁、居住在西欧/北欧/南欧、对基本医疗保险满意、拥有补充医疗保险及频繁就医。尽管接种率上升,欧洲平均流感疫苗接种水平仍低于欧盟75%的目标。
要点
- 2021-2022流感季50岁以上糖尿病患者加权流感疫苗接种率为54%,高于2019-2020季的46%。
- 两个流感季均与接种正相关的因素包括年龄≥65岁、居住在西欧/北欧/南欧、对基本医保满意、有补充医保及频繁就医。
- 欧洲平均接种水平仍低于欧盟75%的目标,研究为ECDC填补了接种覆盖率数据空白。
核心结论
- 尽管2021-2022季接种率较2019-2020季上升,欧洲50岁以上糖尿病患者的平均流感疫苗接种水平仍低于欧盟75%的目标。
- 研究为ECDC填补了50岁以上糖尿病患者流感疫苗接种覆盖率的数据空白,并强调稳健的社会与医疗体系对促进接种的关键作用。
- 作者建议ECDC资助的VENICE网络加强接种知识、通过强化地方项目与资金应对社会经济差异,并与多方利益相关者合作制定区域策略以提高接种率。
研究设计与样本
- 横断面研究,使用欧洲SHARE调查2019-2020和2021-2022流感季数据。
- 纳入50岁以上被诊断为糖尿病的参与者,计算两个流感季的加权流感疫苗接种率。
- 采用多变量分析检验两个流感季接种覆盖率与人口学、身体、社会及医疗因素的关系。
主要发现
- 50岁以上糖尿病患者的加权季节性流感疫苗接种率在2021-2022季为54%,显著高于2019-2020季的46%。
- 两个流感季均与流感疫苗接种正相关的因素包括年龄65岁或以上、居住在西欧/北欧/南欧、对基本医疗保险满意、拥有补充医疗保险及频繁就医。
临床怎么用
- 原文未据此给出针对个体的临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seasonal influenza vaccination coverage data for adults with chronic medical conditions are very scarce. We aimed to investigate the influenza vaccination rates and explore the common social determinants associated with vaccination in Europe across two influenza seasons. METHODS: This cross-sectional study used data from the European SHARE survey for the 2019-2020 and 2021-2022 influenza seasons. Participants over 50 diagnosed with diabetes were included, and weighted influenza vaccination rates for both seasons were calculated. Multivariable analyses were used to examine the relationships between vaccination coverage and demographic, physical, social, and healthcare factors over the two seasons. RESULTS: The weighted seasonal influenza vaccination coverage rate was significantly higher in the 2021-2022 season (54 %) than in the 2019-2020 season (46 %) among people over 50 with diabetes. Factors simultaneously and positively associated with influenza vaccination in both seasons included being aged 65 or older; residing in Western, Northern, or Southern Europe; satisfaction with basic health insurance; having supplementary health insurance; and frequent medical consultations. CONCLUSIONS: Despite the increase, the average European influenza vaccination level remains below the EU target of 75 %. This study fills an important data gap for the ECDC by providing information on influenza vaccination coverage rates among people over 50 with diabetes. The findings highlight the crucial role of a robust social and healthcare system in promoting vaccination. To improve vaccination rates, the ECDC-funded VENICE network should enhance vaccination knowledge, address socioeconomic disparities by strengthening local programs and funding, and collaborate with various stakeholders to develop regional strategies.
引用
- Wang J, Tönnies T, Brinks R, et al. Seasonal influenza vaccination coverage and the social determinants of influenza vaccination among people over 50 with diabetes in Europe: Analyzing population-based SHARE data for the 2019-2020 and 2021-2022 influenza seasons. Vaccine. 2024. PMID: 39709804. doi:10.1016/j.vaccine.2024.126646
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。